Atlas Trials

A Phase 1 First-in-Human Study Evaluating AMG 900 in Advanced Solid Tumors

Clinical trial NCT00858377 · COMPLETED

Trial details

NCT number
NCT00858377
Sponsor
Amgen
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Advanced MalignancyAdvanced Solid TumorsCancerSolid TumorsTumors
Start date
2009-08-10
Primary completion
2014-12-31
Enrollment
95

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.